© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

BNG refreshes euro presence with first deal in 2026

◆ Dutch issuer brings new euro benchmark at last, with social label ◆ Most recent euro line opened over 10 months ago ◆ Peers' bonds helpful to pricing given BNG's absence
SSA
BNG deal 'most exciting' while Eurofima will test long-dated demand

ABN Amro 'deliberately' enhances EuGB senior to meet FIG green bond shortage

There's been a lack of ESG labelled FIG issuance in March, despite this year's volume being higher than last year

GlobalCapital Bond Awards 2026: Voting now open

Have the chance to put forward your opinion and shape this year’s Bond Awards winners.
SSA
BNG deal 'most exciting' while Eurofima will test long-dated demand
Sub-sections
  • The announcement this week that the IMF is on its way to issuing a further $650bn of special drawing rights, providing central banks with extra foreign currency liquidity, should not be criticised for being too little, too late. It marks a much needed return to multilateralism, something that the developing world will benefit from.
  • Organon, the spin-off from US pharma company Merck, has launched a bond leg of its financing, which will establish the unit as a separate firm with its own capital structure, while funding a $9bn dividend to its former parent. The firm was initially offering $4.5bn-equivalent across secured and unsecured bonds, with a bias to the deeper dollar market, but scaled this up during syndication to allow it to strip out bank debt.
  • We Doctor Holdings, which operates Chinese healthcare platform WeDoctor, is seeking approval for a Hong Kong IPO.